A biochemical model of peripheral tinnitus

Hearing Research

Volumn 152, Issue 1-2, 2001, Pages 43-54

  Sahley, Tony L ^a   Nodar, Richard H ^b  

^a CLEVELAND STATE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Dynorphin; Glutamate; Lateral efferent olivocochlear system; N Methyl D aspartate receptors; Stress; Tinnitus

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DIZOCILPINE; DYNORPHIN; EXCITOTOXIN; FENTANYL; GLUTAMATE RECEPTOR; GLUTAMIC ACID; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALOXONE; NORBINALTORPHIMINE; OPIATE RECEPTOR; PENTAZOCINE; SALICYLATE SODIUM;

ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; BIOCHEMISTRY; BRAIN STEM; COCHLEA; DRUG ANTAGONISM; EFFERENT NERVE; HAIR CELL; HUMAN; LONG TERM EXPOSURE; MODEL; NERVE CELL EXCITABILITY; NEUROTRANSMITTER RELEASE; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; STRESS; TINNITUS;

ANIMALS; DYNORPHINS; HUMANS; MODELS, BIOLOGICAL; STRESS; TINNITUS;

EID: 0035130904     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(00)00235-5     Document Type: Article

References (137)

1. Coexistence of putative neuroactive substances in lateral olivocochlear neurons in guinea pig and rat
2. Endogenous opioids: biology and function
3. The many possible roles of opioids and related peptides in stress-induced analgesia
4. Lateral olivocochlear neurons contain both enkephalin and dynorphin immunoreactivities
5. Dynorphin A increases substance P release from trigeminal primary afferent C-fibers
6. Enkephalin suppresses afferent cochlear neurotransmission
7. Intrathecal dynorphin (1-13) results in an irreversible loss of the tail-flick reflex in rats
8. A novel interaction between dynorphin (1-13) and an N-methyl-D-aspartate site
9. Acetylcholine potentiation of glutamate-induced response in guinea pig spiral ganglion cells
10. Selective reversible and irreversible ligands for the κ opioid receptor
11. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence
12. Action of putative neurotransmitters in the guinea pig cochlea
13. Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence
14. GM1 ganglioside-induced modulation of opioid receptor-mediated functions
15. Concentration-response relationships for salicylate-induced ototoxicity in normal volunteers
16. Caroverine in tinnitus treatment
17. Tinnitus and depression
18. Asynchronous neural activity recorded from the round window
19. Effect of sound stimulation at several levels on concentrations of primary amines, including neurotransmitter candidates, in perilymph of the guinea pig inner ear
20. Hyperalgesia and expanded receptive fields
21. Activity-dependent neuronal plasticity following tissue injury and inflammation
22. On the pathophysiology of tinnitus: a review and a peripheral model
23. Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: a survey
24. Ototoxic effects of salicylates on the responses of single cochlear nerve fibres and on cochlear potentials
25. Neurotransmitters and neuromodulators of the mammalian cochlea
26. Opioid receptors inhibit the adenylate cyclase in guinea pig cochleas
27. The role of glutamate at at the afferent synapses of mammalian inner hair cells: a microiontophoretic study
28. A microiontophoretic study of the role of excitatory amino acids at the afferent synapses of mammalian inner hair cells
29. N-Methyl-D-aspartate-induced oscillations in excitatory afferent neurotransmission in the guinea pig cochlea
30. Opioid peptide modulation of circulatory and endocrine response to mental stress in humans
31. Central tinnitus and lateral inhibition: an auditory brainstem model
32. Molecular cloning establishes proenkephalin as precursor of enkephalin-containing peptides
33. Anxiety and depression in tinnitus sufferers
34. Brownian motion in the cochlear partition
35. Salicylate-induced changes in spontaneous activity of single units in the inferior colliculus of the guinea pig
36. Cloning and sequence analysis of cDNA for porcine β-neoendorphin/dynorphin precursor
37. Changes in spontaneous neural activity in the dorsal cochlear nucleus following exposure to intense sound: relation to threshold shift
38. Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions
39. A comparative study of the changes in receptive-field properties of multireceptive and nociceptive rat dorsal horn neurons following noxious mechanical stimulation
40. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors
41. Morphological differences among radial afferent fibers in the cat cochlea: An electron-microscopic study of serial sections
42. Efferent synapses in the inner hair cell area of the cat cochlea: An electron-microscopic study of serial sections
43. Single neuron labeling in the cat auditory nerve
44. Effects of chronic cochlear de-efferentation on auditory-nerve response
45. Single neuron labeling and chronic cochlear pathology. II. Stereocilia damage and alterations of spontaneous discharge rates
46. Single neuron labeling and chronic cochlear pathology. III. Stereocilia damage and alterations of threshold tuning curves
47. Morphometry of intracellularly labeled neurons of the auditory nerve: Correlations with functional properties
48. Modulation of synaptic efficacy as a basis for tinnitis: Hints suggested from the effects of quinine and aspirin on cochlear neurotransmission
49. Excitatory amino acids as a final common pathway for neurologic disorders
50. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study
51. 1 receptor in the rat CNS and pituitary
52. A direct non-opiate interaction of dynorphin (1-13) with the N-methyl-D-aspartate (NMDA) receptor
53. Physiological properties of unmyelinated fiber projections to the spinal cord
54. The influence of sustained opioid receptor blockade in a model of long-term, localized inflammatory pain in rats
55. Increased suceptibility of male rats to kanamycin-induced cochleotoxicity
56. Similarities between chronic pain and tinnitus
57. Temporary threshold shift due to noise exposure in guinea pigs under emotional stress
58. Evidence for the existence of the β-endorphin-sensitive 'ε-opioid receptor' in the brain: The mechanisms of ε-mediated antinociception
59. Molecular analysis of excitatory amino acid receptor expression in the cochlea
60. 'C.A.P.P.E' - a strategy for counseling tinnitus patients
61. Chemical synaptic transmission in the cochlea
62. Electrophysiological evidence for the presence of NMDA receptors in the guinea pig cochlea
63. Implication of non-NMDA and NMDA receptors in cochlear ischemia
64. Pathophysiology of the glutamate synapses in the cochlea
65. Molecular biology of opioid receptors
66. In situ hybridization cytochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia
67. Co-expession of NMDA and AMPA/kainate receptor mRNAs in cochlear neurones
68. Improvement in auditory function following pentazocine suggests a role for dynorphins in auditory sensitivity
69. Effects of opioid drugs on auditory evoked potentials suggest a role of lateral efferent olivocochlear dynorphins in auditory function
70. Pro-dynorphin peptides are co-localized within auditory structures of the Chinchilla brainstem
71. Naloxone blockade of (-)pentazocine-induced changes in auditory function
72. Blockade of opioid-induced changes in auditory function at the level of the cochlea
73. Changes in the auditory neural response following cochlear administration of U-50488H and (-)pentazocine
74. Tinnitus and neural activity
75. Fentanyl anesthesia and human brain-stem auditory evoked potentials
76. Scopolamine, morphine, and brain-stem auditory evoked potentials in awake monkeys
77. Immunohistochemical investigation of enkephalins in the human inner ear
78. Management of tinnitus aurium with lidocaine and carbamazepine
79. Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductance
80. Norbinaltorphimine protection against N-methyl-D-aspartic acid-induced convulsions and mortality
81. Non-opioid effects of dynorphins: possible role of the NMDA receptor
82. Neuroprotective drug therapy: a medical and pharmacological treatment for tinnitus control
83. Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity
84. Endogenous morphine and related opiates, a new class of chemical messengers
85. Calpain inhibitors as neuroprotective agents in neurodegenerative disorders
86. Cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses
87. Mechanisms of salicylate ototoxicity
88. Uptake and release of D-aspartate, GABA and glycine in guinea pig brainstem auditory nuclei
89. Evidence for glutamatergic projections from the cochlear nucleus to the superior olive and ventral nucleus of the lateral lemniscus
90. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long lasting allodynia in rats: blockade by MK-801 but not by naloxone
91. Effect of fentanyl and naloxone on human somatic and auditory-evoked potential components
92. Long-term effects of sectioning the olivocochlear bundle in neonatal cats
93. Efferent innervation of the inner hair cell region: Origins and terminations of two lateral olivocochlear systems
94. Evidence for a central component of post-injury pain hypersensitivity
95. Wind-up and central sensitization are not equivalent
96. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states
97. Auditory-nerve spontaneous rates vary predictably with threshold
98. Effects of kainic acid on the cochlear potentials and distortion product otoacoustic emissions in chinchilla